their investigation on natural killer ( NK ) cells , a type of white blood cell knownto leadthe charge against tumor cells
The next step in this groundbreaking research isto set loosethe charged nanoparticles into animal tumor cells
to undergo apoptosis by Fas clustering or TNF exposure(passive) were triggeredHuman lymphoid tumor CEM cells
PMID : 21555367 ) - Y N 0/0 Addition of doxorubicinresultedDOX)-incorporated nanoparticles to tumor cells
if matured DCs could drived T lymphocytesto triggercytotoxicity against autologous tumor cells
E - cadherin - mediated cell - cell adhesionpreventsinvasiveness of human tumor cells
the cell lineoriginatesfrom human tumor cells
from egcSE - stimulated PBMCscontributeto the cytotoxicity of human tumor cells
Inhibition of E2F transcriptional activityprovokessenescence in human tumor cells
a new class of proteinscausingpreferential agglutination of tumor cells
possiblycausepossibly
in the disruption of cell - cell contacts and EGFR overexpressionresultsin the disruption of cell - cell contacts and EGFR overexpression
genetic changescan causegenetic changes
a dramatic alteration in cell cell contacts and internalization of E cadherincauseda dramatic alteration in cell cell contacts and internalization of E cadherin
a potent anamnestic and persistent anti - tumor T cell response without an apparent sequel of autoimmunitycould triggera potent anamnestic and persistent anti - tumor T cell response without an apparent sequel of autoimmunity
the biochemical mechanisms(passive) triggered bythe biochemical mechanisms
in senescence - like changes , including cell cycle exit and cell shape alterationresultsin senescence - like changes , including cell cycle exit and cell shape alteration
in increased activation of DNA repair elements and reduced activation of apoptotic genes [ 15resultingin increased activation of DNA repair elements and reduced activation of apoptotic genes [ 15
in a slight increase of IL-12 production in CD56 + IFN - DCsresultedin a slight increase of IL-12 production in CD56 + IFN - DCs